Tonry, C.L.; Leacy, E.; Raso, C.; Finn, S.P.; Armstrong, J.; Pennington, S.R.
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer. Diagnostics 2016, 6, 27.
https://doi.org/10.3390/diagnostics6030027
AMA Style
Tonry CL, Leacy E, Raso C, Finn SP, Armstrong J, Pennington SR.
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer. Diagnostics. 2016; 6(3):27.
https://doi.org/10.3390/diagnostics6030027
Chicago/Turabian Style
Tonry, Claire L., Emma Leacy, Cinzia Raso, Stephen P. Finn, John Armstrong, and Stephen R. Pennington.
2016. "The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer" Diagnostics 6, no. 3: 27.
https://doi.org/10.3390/diagnostics6030027
APA Style
Tonry, C. L., Leacy, E., Raso, C., Finn, S. P., Armstrong, J., & Pennington, S. R.
(2016). The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer. Diagnostics, 6(3), 27.
https://doi.org/10.3390/diagnostics6030027